Cytochrome P450 2D6 Polymorphism Is a Molecular Genetic Marker of Liver Cirrhosis Progression

Patients with infectious viral or toxic cirrhosis of the liver participated in complex clinical pathomorphological and molecular-genetic study aimed at the search for markers of predisposition to accelerated liver fibrosis, in which the xenobiotic biotransformation system is involved. The results de...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine Vol. 152; no. 5; pp. 633 - 636
Main Authors: Nepomnyashchikh, D. L., Vavilin, V. A., Aidagulova, S. V., Makarova, S. I., Karavaeva, Yu. Yu, Shchepotina, E. G., Postnikova, O. A., Nokhrina, Zh. V., Vinogradova, E. V., Lyakhovich, V. V.
Format: Journal Article
Language:English
Published: Boston Springer US 01-03-2012
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with infectious viral or toxic cirrhosis of the liver participated in complex clinical pathomorphological and molecular-genetic study aimed at the search for markers of predisposition to accelerated liver fibrosis, in which the xenobiotic biotransformation system is involved. The results demonstrate association between CYP2D6 (1846 G/A) genotype and rapid cirrhosis development and indicate the necessity of studying the mechanisms underlying this association.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0007-4888
1573-8221
DOI:10.1007/s10517-012-1595-x